New Johnson & Johnson CEO Duato points out 5 Pipeline Meds that can Generate $5B+
Synopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…
Synopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…